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a large family, and, indeed, with the recent addition ofTony Hunter
The Salk Institute odorant receptors, this has become by far the largest
receptor family, numbering over a thousand. Analysis10010 North Torrey Pines Road
La Jolla, California 92037 with purified components showed that the liganded re-
ceptor interacts directly with the heterotrimeric G pro-
tein leading to the exchange of GTP for GDP bound toShips that pass in the night and speak
the a subunit, which thereupon dissociates from theeach other in passing
b/g subunits, allowing both the a.GTP and the b/g com-Only a signal shown and distant voice
plexes to signal to downstream effectors, such as ade-in the darkness
nylyl cyclase, again by direct interaction. Sustained sig-ÐHenry Wadsworth Longfellow,
naling in response to a stimulus is generally undesirable,ªThe Theologian's Taleº (1863)
and therefore mechanisms for signal termination are
required. The study of G proteins revealed that signalingThe Past
is turned off when the a subunit hydrolyzes the boundWhen the history of signal transduction is written in
GTP, either spontaneously or upon interaction with a2100, what will be remembered of the exciting advances
GTPase activating protein (GAP), permitting the b/gthat occurred in the latter half of the twentieth century?
complex to rebind.Everyone will surely have their own list of landmark find-
Transmembrane Signaling by Phosphorylationings that have contributed to our current picture of signal
During the 1980s and 1990s several other distinct princi-transduction. Undoubtedly there are seminal earlier
ples of transmembrane signaling have been uncovered.events, but from my own perspective this era began
The discovery of a new class of protein kinases associ-with the discovery in the mid-1950s that phosphorylation
ated with the polyomavirus, v-Src and v-Abl viral trans-can reversibly alter the activity of an enzyme through
forming proteins that phosphorylate tyrosine immedi-the combined action of a protein kinase and a protein
ately suggested that tyrosine phosphorylation plays aphosphatase (Krebs and Beavo, 1979). At much the
role in growth control (Hunter and Cooper, 1985). Tyro-same time the hormones adrenalin and glucagon were
sine phosphorylation was quickly revealed as a majorfound to increase the level of intracellular 3959 cyclic
mechanism of transmembrane signaling. The demon-AMP, and the concept of the second messenger was
stration that EGF stimulated tyrosine phosphorylationborn. About 10 years later the cAMP-dependent protein-
serine kinase (PKA) was isolated as a target for cAMP, EGF receptor in membrane preparations led to the iden-
tification of a large family of ligand-stimulated receptorand through its pleiotropic substrate specificity PKA
was shown to be responsible for many of the effects of protein-tyrosine kinases (PTKs). Receptor PTKs are all
type I transmembrane proteins with a cytoplasmic do-cAMP. With these findings the field of signal transduc-
tion was born. main that has intrinsic catalytic activity that is activated
upon ligand binding. This established that intracellularSince these early days, progress in understanding
mechanisms of signal transduction has been astonish- protein phosphorylation can be used as a direct means
of transmembrane signal transduction. Another impor-ingly rapid. In the past 40 years many important themes
and principles of signal transduction have emerged. The tant step forward in understanding how signals are
transmitted across the membrane came with the discov-highly conserved nature of eukaryotic signaling path-
ways has been revealed, and defects in signaling have ery that receptors lacking intrinsic catalytic activity can
be coupled to nonreceptor PTKs via noncovalent asso-been found as the underlying basis of cancer and other
human diseases. Progress has benefited tremendously ciation with the cytoplasmic domain of a receptor sub-
unit, thus forming ªbinaryº receptors (Neet and Hunter,from structural and genetic analysis, the development
of analytical techniques and reagents, and the availabil- 1996). For instance, cytokine receptors use members of
the JAK PTK family. The discovery of transmembraneity of pharmacological modulators of signaling. What
are some of the major milestones? protein-serine kinases, first in plants and then as recep-
tors for TGFb family cytokines in vertebrates, providedG Protein±Coupled Receptors
The identification of G proteins and their role in activat- another example of the use of ligand-induced intracellu-
lar protein phosphorylation as means of transmembraneing membrane bound adenylyl cyclase to synthesize
cAMP in response to hormonal stimulation in the mid- signal transduction.
The fact that receptor PTKs proved to be type I trans-1970s was another great step forward in understanding
transmembrane signal transduction (Gilman, 1987). The membrane proteins raised the conundrum of how a the-
oretically flexible protein with a single transmembranestudy of G proteins revealed the principle that hydrolysis
of protein-bound GTP could act as a signaling switch, domain could propagate a signal across the membrane
in response to ligand binding. The seminal finding wasand also brought us very near to the membrane receptor
itself. The cloning of hormone receptors that are coupled that activation of receptor PTK cytoplasmic catalytic
domains requires ligand-induced dimerization (Schles-to adenylyl cyclase as well as several neurotransmitter
and drug receptors revealed that they all had a close singer, 1988). This juxtaposes the two catalytic domains
allowing mutual transphosphorylation of residues in therelationship to rhodopsin, the seven transmembrane do-
main G protein±coupled light receptor. This suggested activation loop of the catalytic domain, leading to enzy-
matic activation, and autophosphorylation of tyrosinesthat serpentine G protein±coupled receptors would be
Cell
114
Figure 1. Protein Modules and Signal Trans-
duction
This figure of a cell, showing how modular
protein and lipid interaction domains are used
in a variety of cell signaling pathways, has
been modified from a concept provided by
Tony Pawson.
outside the catalytic domain, which are the key to down- With the identification of the SH2 domain came the
stream signaling. Receptor protein-serine kinases are realization that most protein±protein interaction do-
also activated by ligand-induced dimerization. Subse- mains involved in signal transduction are modular in
quently, ligand activation of many types of surface re- nature (Figure 1). The study of signaling initiated by
ceptor, including those that do not activate protein kinases receptor PTKs and other protein kinases has uncovered
directly, has been found to involve oligomerization. a plethora of different protein interaction domains, rang-
Protein Signaling Modules ing in size from 40 to 150 residues, used for inducible or
The discovery of the SH2 domain as a means of recog- constitutive interactions involved in signaling (Pawson,
nizing specific phosphorylated tyrosines in activated 1995). Examples are SH2, PTB, SH3, WW, FHA, SAM,
receptor PTKs and receptor PTK targets was a break- LIM, PX, EH, EVH1, and PDZ domains. Like the SH2
through in understanding how activated PTKs propa- domain, most of these domains recognize short linear
gate signals, since it revealed how the association of sequences from 4 to 10 amino acids in length, in some
two proteins could be induced by phosphorylation thus cases requiring phosphorylation of a specific Ser/Thr
propagating a signal (Pawson and Gish, 1992). Indeed, or Tyr within the recognition sequence, thus providing
this discovery illustrated a totally new function for pro- inducible association. These domains fold indepen-
tein phosphorylation, namely the regulation of protein± dently and their N and C termini protrude from one side
protein association. Other types of phosphotyrosine of the domain with the interaction surface on the oppo-
(P.Tyr)-binding domain have subsequently been found site side, allowing them to be assembled almost like
(e.g., PTB domains), but SH2 domains are the most beads on a string (Kuriyan and Cowburn, 1997).
prevalent type of P.Tyr-binding domain involved in sig- Another important step forward was the discovery
naling downstream of activated receptor PTKs. SH2 do- that domains involved in membrane signaling can recog-
mains bind in a sequence-specific fashion, recognizing nize molecules other than proteins. For instance, plecks-
one or more residues in positions 1±6 C-terminal to the trin homology domains (PHD), found in many signaling
P.Tyr. PTB domains recognize residues up to 5 away
proteins, recognize specific phospholipids and thus
on the N-terminal side of P.Tyr, but only a subset of
allow inducible membrane association dependent on
PTB domains (e.g., the Shc and IRS-1 PTBs) bind to their
the formation of lipid second messengers (Ferguson ettarget proteins in a phosphorylation-dependent manner
al., 1995). For example, the PHDs of the PDK1 and Akt/(van der Geer and Pawson, 1995).
PKB protein-serine kinases bind PIP3 and this promotesSH2 and PTB domain interactions are used as a means
their membrane recruitment in response to PI-39 kinaseof recruiting target proteins to activated PTKs, thus per-
activation and leads to activation of Akt/PKB by PDK1.mitting their phosphorylation, and also for translocation
Ca21 elevation can regulate membrane association ofto the plasma membrane, where many effector proteins
proteins via Ca21-dependent interaction of C2/CalB do-activated by receptor PTKs, such as phospholipase Cg
mains with phospholipids.and PI-39 kinase, have their substrates (Schlessinger,
Recently, phosphoserine (P.Ser)-binding domains have1994). SH2/PTB domains are present not only in proteins
also been identified, and these too play roles in signalwith intrinsic enzymatic activity that can be regulated
propagation, by facilitating phosphorylation-dependentby tyrosine phosphorylation, such as phospholipase Cg,
protein±protein interactions (Yaffe and Cantley, 1999).but also in so-called adaptor proteins, such as Grb2,
The first example was the phosphorylation-dependentthat bind to and thereby bring effector enzymes to the
binding of the CBP coactivator protein to the CREBplasma membrane. Receptor-induced recruitment of
transcription factor when phosphorylated at Ser133.proteins to the plasma membrane as a mechanism of
Subsequently, other families of P.Ser/P.Thr-binding do-activating signaling pathways has emerged as a major
theme in signaling. mains have been found.
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Intracellular Signaling Pathways translocates to the nucleus. An important step in under-
standing the cAMP pathway was the identification ofFollowing the identification of the transmembrane re-
ceptors, and their proximal targets, intracellular signal- the CREB transcription factor, which binds to cAMP
response elements in inducible genes, and the demon-ing pathways were the next to come on stage. The emer-
gence of a large family of small monomeric G proteins, stration that it is a nuclear target for PKA. Once the C
subunit enters the nucleus it phosphorylates CREB atheralded by Ras, was an important step in understand-
ing transmembrane signaling. Ras is anchored via C-ter- Ser133, triggering binding of the CBP/p300 coactivator
and transcription of cAMP-responsive genes. This find-minal lipid modifications to the inner face of the plasma
membrane, and, like heterotrimeric G proteins, is acti- ing reinforced the notion that transcytoplasmic signaling
pathways could use transcription factor phosphoryla-vated by GTP-GDP exchange catalyzed by GTP ex-
change factors. Ras.GTP levels are increased upon tion as a regulatory mechanism. Many transcription fac-
tors are now known to be directly regulated by phos-activation of many types of receptor. A key to under-
standing how Ras is activated was the finding that the phorylation, through positive or negative control of
nuclear import or export, DNA binding, or transactivationCdc25-related Sos protein has Ras.GTP exchange fac-
tor activity, and that the Grb2 SH2/SH3 adaptor protein activity (Karin and Hunter, 1995).
MAP Kinase Pathwaysis constitutively associated with Sos via its SH3 domains
(Schlessinger, 1993). The Grb2/Sos complex is recruited Two separate lines of inquiry, namely analysis of protein-
serine kinases activated by receptor PTKs and the studyto an activated receptor PTK upon binding of the Grb2
SH2 domain to an autophosphorylated tyrosine in the of transcription factor phosphorylation, converged to
establish that the MAP kinase pathway is a major mech-appropriate sequence context, thus bringing the Sos
catalytic domain into proximity with Ras at the plasma anism for controlling transcription in eukaryotes (Seger
and Krebs, 1995). MAP kinase was originally discoveredmembrane and stimulating GTP exchange. Once acti-
vated, Ras.GTP interacts with a series of effector pro- as an insulin-activated protein-serine kinase, and bio-
chemical studies, reinforced by genetic analysis of theteins, including the Raf protein-serine kinase and PI-39
kinase, which initiate downstream signaling (Witting- pheromone response in budding yeast, showed that this
pathway consists of a cascade of three protein kinases,hofer and Nassar, 1996). Analysis of Ras function also
led to the discovery of the first GAP, which stimulates a MAP kinase kinase kinase (MAPKKK), a MAP kinase
kinase (MAPKK), and a MAP kinase (MAPK) (WaskiewiczGTP hydrolysis and thus acts to terminate Ras signaling
(McCormick, 1989). Other small G proteins also function and Cooper, 1995). These protein kinases are activated
in series, such that the MAPKKK phosphorylates theas signaling switches that are activated by receptor-
induced GTP exchange. For instance, the Rho family MAPKK at serines in its activation loop, which is thereby
activated and phosphorylates the MAPK at a threoninesmall G proteins, Rho, Cdc42, and Rac, are all activated
via receptor signaling pathways, and, like Ras, induce and tyrosine in its activation loop, leading to its activa-
tion. Every eukaryotic organism has multiple MAPKdivers signaling pathways, which lead to gene expres-
sion and, perhaps more importantly, cause dramatic pathways, which are largely separate from one another.
The elucidation of the modular MAPK cascade with itsrearrangements in the actin cytoskeleton.
Ras was the first signaling protein whose function was three consecutive protein kinases had immediate impli-
cations for understanding signal amplification and switch-shown to be conserved from yeast to vertebrates, and
this presaged the identification of many highly con- ing, and most importantly for nuclear signaling, because
the terminal MAPK, once activated, can migrate into theserved signaling pathways throughout the eukaryotic
kingdom. A prime example is the receptor PTK-Ras- nucleus, and there phosphorylate and activate tran-
scription factors.MAP kinase pathway, where genetic and biochemical
analysis has revealed that this pathway exists in essen- Nuclear Translocation of Transcription Factors
Receptor-induced nuclear translocation of a latent cyto-tially identical form in species ranging from nematodes
to vertebrates, with most of the components being func- plasmic transcription factor into the nucleus emerged
as a different transcytoplasmic signaling principle. Thetionally interchangeable between organisms.
Transcriptional Regulation by Surface Receptors NF-kB activation pathway provided the first example
of a cytoplasmically sequestered transcription factorvia Transcytoplasmic Signaling
Upon binding ligand, many receptors invoke gene ex- (Karin and Hunter, 1995). In this case, NF-kB is held in
the cytoplasm through binding to an inhibitor protein,pression responses. Indeed, the discovery that growth
factors induce de novo expression of a specific set of IkB, which masks the nuclear localization signal in the
NF-kB heterodimer. Activating stimuli induce phosphor-genes independent of new protein synthesis led to the
search for transcytoplasmic signaling pathways that ylation of IkB, at specific sites, which targets it for ubiqui-
tin-mediated degradation, thus releasing active NF-kBregulate transcription (Karin and Hunter, 1995). In the
past 10 years, there has been spectacular progress in to migrate into the nucleus. The simplest pathway of
this sort is the JAK/STAT system, in which ligand bindingunderstanding how plasma membrane signals are trans-
mitted to the nucleus. The first and simplest transcyto- to a cytokine receptor activates associated JAK family
PTKs, which first phosphorylate receptor subunits andplasmic nuclear signaling mechanism to be identified
was the PKA/CREB system (Montminy et al., 1990). In then specific STAT transcription factors, whereupon the
STATs dimerize, migrate to the nucleus and activatethis pathway, cAMP, elevated in response to receptor
stimulation, activates the R2C2 PKA holoenzyme local- transcription (Karin and Hunter, 1995). Other examples
are activation of the Wnt/Frizzled pathway, which resultsized in the cytoplasm by binding to the regulatory (R)
subunits, thus releasing the catalytic (C) subunit which in translocation of b-catenin/LEF1 transcription factor
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complexes into the nucleus, and activation of TGFb fam- 1989). The discovery of calmodulin as a major Ca21-
ily receptors, which leads to phosphorylation of recep- sensing protein in the cells, and identification of protein
tor-specific Smad transcription factors, which then as- targets for Ca21/calmodulin complexes, including a fam-
semble with the common Smad4 subunit, translocate ily of Ca21/calmodulin activated protein kinases, has
into the nucleus, and induce transcription of target provided us with an explanation for how Ca21 release
genes. is translated into molecular consequences. Moreover,
Signaling via Notch family receptors utilizes the novel the development of cell-permeant Ca21 sensor fluoro-
principle of ligand-induced proteolytic cleavage releas- phores has afforded us with the most detailed spatio-
ing the Notch cytoplasmic domain, which acts as a pro- temporal picture of signaling events occurring in the
tein second messenger that migrates to the nucleus and cell. The intricate and dynamic real-time patterns of local
regulates gene expression by binding into and con- and global Ca21 release and resorption and the propaga-
verting the suppressor-of-hairless transcriptional re- tion of Ca21 waves and oscillations are surely the harbin-
pressor into a transcriptional activator (Artavanis-Tsa- ger of how other signaling systems work at the subcellu-
konas et al., 1999). lar level.
Nuclear Receptors New Second Messengers
The finding that lipid-soluble ligands, such as retinoic With cAMP, cGMP, and IP3 the concept of the second
acid, estrogen, and other hormones, can traverse the messenger was well established. However, the discov-
plasma membrane without utilizing surface receptors ery that NO is the endothelial cell±derived relaxing factor
and induce cellular responses by binding to and activat- for vascular smooth muscle and that NO activates solu-
ing members of a family of zinc finger transcription fac- ble cytoplasmic guanylyl cyclase to elevate cGMP re-
tors revealed yet another nuclear signaling mechanism vealed, somewhat unexpectedly, that a gas could act
(Mangelsdorf et al., 1995). These so-called nuclear re- as a second messenger (Murad, 1994). This finding re-
ceptors prove to be a huge family that transduce tran- kindled interest in cGMP-mediated signaling, which is
scriptional responses to an astonishing variety of chemi- mainly effected by the cGMP-dependent protein kinase,
cals. In principle, the nuclear receptors represent the although there are other targets for cGMP.
simplest possible mechanism for nuclear signaling, al- Signaling in Prokaryotes and Plants
though analysis of how ligand binding activates recep- Although much of the emphasis in signal transduction
tor-mediated transcription of target genes reveals a sur- has been on eukaryotes, prokaryotes should not be ne-
prisingly complex machinery in which the unliganded glected in this litany of progress. For instance, an impor-
receptor heterodimer acts as repressor as a result of tant new signaling principle was established with the
its association with histone deacetylases, and ligand discovery of the two component histidyl-aspartyl phos-
binding converts the receptor into an activator by trig- phorelay systems, comprised of a sensor ªhistidineº
gering dissociation of histone deacetylases and recruit- protein kinase that phosphorylates a response regulator
ment of histone acetylases. on an aspartate residue (Stock et al., 1990). These sys-
Phospholipid- and Ion-Based Signaling tems allow prokaryotes to respond to a wide variety of
The discovery in the 1960s of the phosphatidylinositol extracellular stimuli. However, somewhat surprisingly,
(PI) cycle, which results in stimulus-induced turnover of two component systems are rare in eukaryotes, and
PIP2, was the harbinger of the finding of a series of for the most part seem to have been superseded by
phospholipid-derived second messengers, including di- conventional protein kinases.
acylglycerol (DAG), IP3, and PI3,4,5P3, and more recently Likewise, although animals and fungi have received
IP4 and IP6 (Liscovitch and Cantley, 1994). The identifica- the lion's share of attention, plants have also taught us
tion of protein kinase C as a DAG-regulated enzyme new principles in signal transduction. For instance, the
provided another example of a second messenger-regu- first receptor protein-serine kinases were found in
lated protein kinase. Phospholipase action on PIP2 not plants, and one type of leucine-rich receptor kinase may
only generates DAG but also IP3, which acts as a second be directly regulated by plant steroid family ligands.
messenger to release Ca21 from intracellular stores, thus
Moreover, ethylene, an important plant hormone, wastriggering a program of Ca21-activated events. The un-
the first gas shown to induce cellular responses, andexpected discovery of PI-39 kinases and the family of
significant progress has recently been made in under-39 phosphoinositides they generate led to the elucida-
standing how ethylene signals.tion of a new phospholipid-based signaling system in
which proteins are recruited via PIP3-binding PH do-
The Futuremains to the membrane where they are activated (e.g.,
What does the future hold? There are many areas inthe Akt/PKB protein-serine kinase) (Kapeller and Cant-
signaling where it is safe to predict that rapid progressley, 1994).
will be made, but because of its preeminence as a mech-The regulated entry and exit of ions across the plasma
anism of signal transduction, most attention will be paidmembrane, through ligand-gated, voltage-sensitive and
to protein phosphorylation and its role in intracellularstretch-activated ion channels and via ion pumps, has
signaling.important signaling functions, particularly in impulse
Modular Protein Interaction Domains in Signalingpropagation in the nervous system and in muscle con-
A central theme in receptor-initiated signaling is the usetractility. Receptor-induced changes in cytoplasmic and
of modular protein±protein interaction domains, eithernuclear Ca21 levels as a result of release of membrane-
for inducible or constitutive interactions (Pawson, 1995).bound Ca21 stores through IP3 or entry of extracellular
Well over a hundred putative protein domains have beenCa21 through plasma membrane ion channels constitute
an important signaling mechanism (Berridge and Irvine, defined by comparative sequence analysis (http://smart.
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EMBL-Heidelberg.de). Although the function of many of signaling complexes. FHA domains bind pTXXD motifs
these domains is known, many remain uncharacterized in proteins, such as Rad9p involved in DNA damage
and a majority of them could prove to be new protein± responses. One group of WW domains bind P.Ser/
protein interaction domains utilized in signaling path- P.Thr.Pro motifs in mitotic phosphoproteins and in the
ways. Partners for these domains can be identified by RNA polymerase II large subunit CTD. A subset of WD40
two-hybrid screens and affinity methods combined with domains and leucine-rich repeats can also recognize
the use of degenerate peptide libraries to establish a P.Ser. Given the great potential and specificity of phos-
binding consensus sequence. Several phospholipid in- phorylation-induced protein interaction as a signal trans-
teraction domains, including PH and FYVE domains, are fer mechanism, it is a good bet that additional P.Ser/
already known that provide inducible membrane associ- P.Thr-binding domains will be discovered.
ation in response to generation of lipid second messen- Induced Protein Proximity in Signaling
gers (e.g., PIP3) or stabilize membrane association of Another overriding principle that has emerged from anal-
signaling proteins via binding to constitutive membrane ysis of receptor-activated signaling pathways is that
phospholipids. Given the importance of membrane re- signaling can be initiated and propagated using the prin-
cruitment in signaling, additional lipid recognition do- ciple of induced protein proximity (Austin et al., 1994).
mains seem certain to be discovered. Identification of As described above, ligand binding to receptor PTKs
nonprotein targets for such domains should be aided initiates signaling by causing dimerization, which facili-
by affinity chromatography combined with mass spec- tates transphosphorylation. Recruitment of proteins
trometric analysis. with P.Tyr-binding domains to activated membrane-
The finding that short linear motifs were sufficient localized receptors where they can be phosphorylated
for recognition by protein interaction domains came as or act on membrane targets is another example. This
something of a surprise, given the complex nature of mechanism elevates the local concentration of proteins
the subunit interaction surfaces found in multisubunit at the membrane thereby increasing the number of pro-
proteins. However, the fact that recognition only re- ductive signaling complexes. SH2 domain binding also
quires such short sequences combined with the func- greatly increases the affinity of these proteins as sub-
tional independence of these domains presumably strates for phosphorylation by activated receptor PTKs.
facilitated the rapid genesis of new protein±protein A dramatic illustration of the importance of protein prox-
interactions during evolution. Indeed, how easily these imity has been afforded by the use of artificial ligand-
domains could be duplicated and used to evolve new binding domains fused to signaling proteins that can
signaling proteins is illustrated by the experimental por- then be induced to oligomerize by membrane-permeant
tability of these domains. For example, replacement of dimeric chemical ligands. In several cases, this has been
the C terminus of the Sos Ras activator with the Grb2 found to trigger the activation of signaling pathways just
SH2 domain yields a fusion protein that largely rescues as efficiently as extracellular ligands (Spencer et al.,
the defects in Grb22/2 ES cell differentiation (Cheng et 1993).
al., 1998). The ability to make chimeric signaling proteins Induced protein proximity is used to activate signaling
of this sort to test hypotheses about specific signaling pathways by many other receptor systems, particularly
connections will be increasingly useful as an analytical the TNF, IL-1, Toll, and death receptors, where initial
tool. signaling events are critically dependent on oligomeric
Phosphorylation-Dependent Protein± protein±protein interactions. The subset of TNF family
Protein Interaction receptors that promote cell death use homotypic inter-
In just 10 years it has become apparent how widely used actions between death domains, death effector domains
sequence-dependent P.Tyr recognition is for tyrosine and CARD domains to trigger an intracellular signaling
phosphorylation-mediated signaling. To add to the well- cascade that involves sequential proteolytic activation
established SH2 and PTB domains, novel P.Tyr-binding
of a series of proenzymes in the caspase protease fam-
domains have recently been identified in c-Cbl, IRS-2,
ily. In death receptor-induced caspase activation, pro-
and Gab1. Interestingly, structural analysis indicates
tein proximity is used to accentuate the low basalthat the P.Tyr-binding domain in c-Cbl is a variant SH2
catalytic activity of a procaspase leading to efficientdomain (Meng et al., 1999), whereas the Gab1 P.Tyr-
autoprocessing in the context of an oligomer (Salvesenbinding domain appears to have a novel structure. Addi-
and Dixit, 1999).tional P.Tyr-binding domains are likely to be identified,
A new concept in protein proximity has emerged fromalthough they probably will not be large families. A dis-
the study of signaling by receptor PTKs. Although ittinct type of P.Tyr-binding domain is exemplified by the
is well established that ligand-induced dimerization isªanti-phosphatasesº, which are proteins structurally re-
required for activation of receptor PTKs, recent evi-lated to the PTP or dual-specificity phosphatase fami-
dence suggests that dimerization per se may not belies, but which lack one or more of the residues essential
sufficient for activation, and that there is an additionalfor catalytic activities, and therefore can bind but not
requirement for the relative orientation of the two dimerhydrolyze P.Tyr-containing proteins (Hunter, 1998a).
subunits to be such that the catalytic domains are cor-Although it has only recently been appreciated that
rectly juxtaposed (Jiang and Hunter, 1999). In fact, thereP.Ser/Thr can also be recognized by modular binding
is good evidence in some systems that receptor dimersdomains, three families of sequence-specific P.Ser/Thr-
can exist in the absence of ligand, and that ligand-binding domains are already known (Yaffe and Cantley,
induced conformational switches in preformed recep-1999). 14-3-3 proteins, which recognize RSXpSXP and
tors are critical for activation of the catalytic domains.RXY/FXpSXP motifs, bind many protein kinases, and as
a result of their dimeric nature can potentially assemble In this context, an understanding of the way in which
Cell
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Figure 2. Ribbon Diagram Showing the Struc-
ture of the c-Src Protein-Tyrosine Kinase in
Its Inactive State Bound to AMP-PNP
This figure is reproduced with permission
from Xu et al. (1999).
multimeric ligands are presented to receptors will be Structural analysis of protein kinase and phosphatase
catalytic domains bound to inhibitors and protein inter-increasingly important.
Structural Analysis of Signaling Proteins action domains bound to ligands is now a routine step
in the development of drugs that inhibit activity or blockMany of the most important advances in understanding
signaling pathways initiated by tyrosine phosphorylation interactions, for therapeutic use in diseases where sig-
naling is deregulated. The structures of protein kinaseshave come through the determination of the three-
dimensional structures of PTKs and PTPs, their immedi- bound to protein (e.g., p16/Cdk6) and chemical (e.g.,
FGFR1 receptor PTK bound to SU5402 and PD173074)ate targets, including modular domains such as SH2, SH3,
PTB and PH domains, and downstream components, inhibitors have provided insights into how inhibition is
brought about and how selectivity is achieved, and thisincluding protein-serine kinases and phosphatases.
Structural analysis of signaling proteins has already promises to accelerate the pace of development of spe-
cific small molecule or peptide-based inhibitors (Mo-revealed new and unexpected principles of regulation.
For instance, the structures of several protein kinases hammadi et al., 1997, 1998; Russo et al., 1998). More-
over, based on inhibitor-bound protein kinase structureshave shown how the ªactivationº loop acts as a negative
regulator of activity, by blocking ATP and/or substrate it is possible to make mutant protein kinases resistant
to a specific inhibitor that can be expressed and usedbinding, and how rotation of the C helix in the N-terminal
lobe is used as a regulatory principle. The structure of to pinpoint which responses are a direct consequence
of that protein kinase (Eyers et al., 1999).the c-Src PTK in its inhibited P.Tyr527-phosphorylated
state revealed that the SH2 and SH3 domains bound to Structures of most of the well-characterized protein
and lipid interaction domains have been generated.P.Tyr527 and the SH2-catalytic domain linker, respec-
tively, lie on the backside of the catalytic domain, instead Comparative analysis of multiple examples of these do-
mains bound to their ligands has given us importantof blocking substrate access to the catalytic cleft as
had been expected (Figure 2). In fact, c-Src activity is insights into ligand binding specificity. Indeed, analysis
of SH2 domains bound to P.Tyr-containing peptides hasinhibited indirectly as a result of a conformational
change propagated through the small N-terminal lobe made it possible to make designer point mutations that
alter SH2 domain sequence-binding specificity in a pre-that leads to rotation of the C helix and distortion of the
active site (Xu et al., 1999). The dimeric structure of dictable way. Likewise, a point mutation in the WW do-
main can transform its ligand specificity (Espanel andcatalytic domain 1 of RPTPa led to the prediction that
receptor PTP activity can be negatively regulated Sudol, 1999). This heralds the possibility of designing
unique signaling pathways with customized signalingthrough a symmetrical D1 dimer interaction in which a
helix-turn-helix motif blocks access to the catalytic cleft components.
An area of structural understanding that has lagged(Bilwes et al., 1996). Likewise, the N-terminal SH2 do-
main was found to be bound to the catalytic cleft of the behind is the molecular basis of functional regulation
by protein phosphorylation. There are very few struc-Shp2 PTP thus blocking substrate access, an interaction
that is reversed upon the binding of a P.Tyr-containing tures of proteins in both their phosphorylated and un-
phosphorylated states. The structures of the phospho-protein ligand to the SH2 domain leading to exposure
of the active site (Hof et al., 1998). The structures of Ras and dephospho-forms of glycogen phosphorylase and
isocitrate dehydrogenase kinase show that addition ofand trimeric G proteins bound to GTP and GDP have
revealed how GTP hydrolysis results in a conformational a phosphate can induce a local conformational change
increasing substrate affinity or a steric block to substrateswitch that blocks binding of effector proteins. Undoubt-
edly additional regulatory principles will be identified binding, respectively. Several protein kinases structures
reveal how activation as a result of phosphorylation ofthrough structural analysis. Moreover, as molecular
docking programs become more sophisticated it may be residues in the catalytic domain activation loop occurs
through a local conformational change that allows ATPpossible to predict which signaling proteins can interact.
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and protein substrate access to the active site. Struc- particular, the PP2A protein-serine phosphatase has a
large number of regulatory subunits that dictate sub-tures of many more proteins in their phosphorylated and
strate specificity and localization. There are severalunphosphorylated states will be needed to determine
known inhibitor proteins for PP1 (e.g., inhibitor 1 andthe structural principles underlying functional regulation
inhibitor 2), some of which require phosphorylation toby phosphorylation.
be active, and there is some evidence for PTP inhibitorProtein Kinase and Phosphatase Regulation
proteins. PTPs are also regulated by phosphorylationProtein kinases can be regulated by second messen-
and by subcellular localization. There is a large familygers, by allosteric mechanisms, by intrasteric inhibition
of receptor-like PTPs whose activity could theoreticallythrough pseudosubstrate sequences, by positive and
be regulated by ligands. In some instances receptor-likenegative phosphorylation events, by regulatory subunit
PTPs appear to be negatively regulated by dimerizationbinding, by inhibitor proteins and by subcellular localiza-
(e.g., RPTPa and CD45) (Majeti et al., 1998), in a mirrortion through targeting domains and anchoring proteins.
image fashion to the activation of receptor PTKs byWill new mechanisms of protein kinase and phospha-
dimerization. The identification of ligands that regulatetase regulation emerge? Additional second messengers
receptor PTP dimerization will be an important step for-and nonprotein regulators are likely to be added to the
ward in understanding these enzymes.current list, which includes cAMP, cGMP, DAG, Ca21/
Spatiotemporal Aspects of Signalingcalmodulin, polyamines, double-stranded RNA, and
An area that will be increasingly important is the spatio-double-stranded DNA ends. Sphingosine and ceramide
temporal aspects of signaling by protein kinases andare potential second messengers that reportedly regu-
phosphatases. Over the past few years, it has beenlate protein kinases; cyclic ADP-ribose and sphingosine
appreciated that protein kinases and phosphatases and1-phosphate and other recently described second mes-
their substrates are often discretely localized in the cell,sengers, such as IP6, may also prove to regulate protein
and that this is critical for specificity of phosphorylation.kinases. New second messengers may be identified
The finding that signaling components are highly orga-through mass spectrometric analysis of total low molec-
nized at the plasma membrane, in the cytoplasm, andular weight compounds in extracts of stimulated cells.
in the nucleus suggests that there are discrete signalingConversely, one should be aware that second messen-
domains within the cell. Traditionally, the transduction
gers known to regulate protein kinases might have other
of signals was thought to involve freely diffusible enti-
functions. For example, that most venerable of second
ties, and this is indeed the case for second messengers
messengers, cAMP, has recently been shown to regu-
like cAMP. However, pathways that involve predomi-
late a Rap1 guanine-nucleotide-exchange factor (de nantly protein components may signal in a semi±solid
Rooij et al., 1998), suggesting that cAMP, like cGMP, state fashion with minimal free diffusion. Moreover, sig-
has multiple intracellular targets. naling proteins may be directionally transported via fila-
Protein mass spectrometry is leading to the identifica- ment-bound motor proteins or by vesicular transport.
tion of new types of posttranslational modification, and This leads to the idea that signals can be channeled
some of these modifications may be used to regulate through specific routes from the membrane to the nu-
protein kinase and phosphatase activity. An attractive cleus and other destinations and that there may be spe-
possibility is that nuclear protein kinases and phospha- cific cellular compartments that are competent to relay
tases involved in transcription might be regulated by signals. This mechanism would be expected to greatly
acetylation. Additionally, the HIPK2 protein-serine ki- enhance the efficiency and specificity of signal trans-
nase is modified by SUMO-1 (Kim et al., 1999), sug- mission.
gesting that modification by members of the ubiquitin Anchoring and Scaffolding Proteins. Anchoring pro-
family might also regulate protein kinase function. teins are often used to localize protein kinases and phos-
Intracellular protein inhibitors of protein kinases have phatases to their substrates in particular places in the
been known for many years (e.g., PKI for PKA, p21, and cell (Pawson and Scott, 1997). This increases the effi-
p16 family Cdk inhibitors). Generally, these inhibitors are ciency and specificity of substrate phosphorylation and
highly specific for individual protein kinases, as would coordinates the actions of protein kinases and phospha-
be expected given that they work on the principle of tases. The best studied anchoring proteins are the
protein±protein interaction. New protein kinase inhibitor AKAPs that are used to localize PKA, via its R subunits,
proteins continue to be reported, and increasingly these and its substrates to particular places in the cell. For
are likely to be of physiological importance. example, AKAP18, a myristoylated protein is localized
Protein Phosphatases and Signaling to the plasma membrane where it binds PKA and the
In any process governed by protein phosphorylation, L-type Ca21 channel, a PKA target (Colledge and Scott,
regulation of the protein phosphatase(s) is just as likely 1999). Anchoring proteins are also known for TGFb RI,
to be important as regulation of the protein kinase where SARA is used to recruit Smad proteins and to
(Hunter, 1995). Indeed, although initially regarded as localize the signaling complex to discrete membrane
constitutively active enzymes that reversed the action regions via a FYVE domain (Tsukazaki et al., 1998), and
of inducibly activated protein kinases, the regulation of for protein kinase C, where RACKs are used for mem-
protein phosphatases is proving to be highly sophisti- brane localization. Undoubtedly, many more anchoring
cated. Protein phosphatase activity can regulated by proteins await discovery.
posttranslational modification (e.g., phosphorylation and A different means of bringing signaling components
methylation), second messengers (e.g., Ca21/calmodulin together is through the formation of multiprotein com-
plexes through protein±protein interaction domains. Inand PP2B), targeting subunits, and inhibitory proteins. In
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this regard, one important principle is the use of scaf- of the FKHR transcription factor by Akt/PKB results in
nuclear export (Brunet et al., 1999). Vesicular proteinfolding proteins to assemble sequential components of
a signaling pathway (Garrington and Johnson, 1999). trafficking may also be used as a mechanism of signal
transduction. For instance, most ligands induce endocy-The best characterized example is Ste5, a scaffolding
protein that interacts with the Ste11, Ste7, and Fus3p/ tosis of their receptors, and there is increasing evidence
that receptors internalized in endocytic vesicles carryKss1p protein kinases in the mating pheromone MAPK
pathway. Scaffolding proteins are known for the JNK/ out specialized signaling functions.
Temporal Aspects. Historically, signaling has beenSAPK and ERK MAPK pathways as well. Individual mem-
bers of a MAPK pathway can also serve as scaffolds studied in populations of cells, but it is clear that there is
significant kinetic variation in the responses of individualby interacting with other protein kinases in the same
pathway. An important property of many scaffolding cells to a stimulus. This underscores the importance of
developing tools to study signaling at high resolutionproteins is their ability to dimerize, which allows phos-
phorylation in trans between protein kinase molecules in single cells, as has been done for Ca21 signaling.
Extensive use is already being made of GFP-fusion pro-bound to different subunits in the dimer. A deeper under-
standing of how assemblies of signaling proteins are teins to study the real-time movement of signaling mole-
cules such as protein kinases in single living cells inbuilt up is clearly important.
Plasma Membrane Signaling Domains. Another higher response to extracellular stimuli. For instance, translo-
cation to the plasma membrane of various isoforms oforder principle of signal localization is afforded by
plasma membrane signaling domains. Membrane mi- PKC fused to GFP can be detected in response to recep-
tor stimulation (Sakai et al., 1997; Oancea and Meyer,crodomains known as caveolae, marked by the pres-
ence of an intracellular protein coat comprised of caveo- 1998). SH2-GFP fusion proteins are being used to study
the localization of tyrosine phosphorylation eventslin, can be isolated in a detergent-insoluble cholesterol/
glycolipid-rich fraction (Kurzchalia and Parton, 1999). (Stauffer and Meyer, 1997), and PH domain±GFP fusions
to study where PIP2 and PIP3 are generated in vivoBy virtue of this property, caveolae are found to be
enriched for many membrane signaling proteins, usually (Stauffer et al., 1998). A better knowledge of the exact
timing of the onset and termination of signaling andlocalized by GPI linkages or palmitoyl groups. These
lipid rafts are estimated to contain 50±100 protein mole- the speed of movement of signals combined with their
precise location will be a key to understanding signalingcules, and this could be a means of concentrating signal-
ing proteins for more efficient interaction. Another exam- output.
Signaling Networks and Signaling Specificityple of a discrete plasma membrane signaling domain
are focal adhesions, which are organized membrane- One of the major challenges in understanding signaling
networks is to elucidate how signaling specificity isassociated structures where clustered integrins bind to
extracellular matrix proteins and to the actin cytoskele- achieved when many of the same core signaling path-
ways are activated by receptors that elicit different cellu-ton, and which mediate integrin signaling through tyro-
sine and serine phosphorylation. lar responses (Tan and Kim, 1999). For instance, why
does activation of the PI-3 kinase pathway by the insulinYet another mechanism of organizing proteins on the
inner face of the membrane is through the use of proteins receptor PTK lead to metabolic responses such as trans-
location of the GLUT4 glucose transporter, whereas acti-with multiple PDZ domains (Fanning and Anderson, 1999).
PDZ domains bind to short C-terminal E.S/T.X.V/ICOOH vation of PI-3 kinase by growth factor receptor PTKs
in the same cell does not? Signaling specificity can inmotifs, and a single protein can have up to 20 PDZ
domains. A good example of a submembraneous PDZ principle result from the activation of unique signaling
pathways by a receptor. Alternatively, since cellular re-organizing protein is InaD, which contains 5 PDZ do-
mains with different specificities and can also dimerize. sponses reflect an integration of outputs from all the
pathways activated by a single receptor, signaling spec-InaD interacts with multiple components of the visual
signaling system in photoreceptors in the Drosophila ificity can also result from a unique combination of sig-
naling pathways activated by the receptor. Receptoreye, including rhodopsin, thus concentrating all the nec-
essary components into complexes and thereby speed- PTKs use not only autophosphorylation site tyrosines
but also phosphorylate-specific docking proteins (e.g.,ing up signal transmission. An understanding of how
membrane proteins involved in signaling are organized IRS1/2 for the insulin receptor PTK and FRS2 for the
FGF and NGF receptor PTKs) to diversify signaling andon the inner face of the membrane will be increasingly
important. provide specificity. The exact location of ligand-acti-
vated receptors on the cell surface may dictate whichSignaling Protein Translocation. Regulated protein lo-
calization has emerged as a fundamental principle in pathways can be activated, thus using spatial separa-
tion as another means of generating specificity. Cellsignaling, and spatial separation of proteins is com-
monly used as a mechanism for preventing spontaneous type±specific nuclear responses to activation of a given
receptor can be explained by the expression of differentsignal activation. In addition to local movement of pro-
teins, exemplified by inducible membrane association repertoires of downstream signaling proteins including
transcription factors, and by which active chromatin do-of cytoplasmic P.Tyr-binding domain proteins, longer
range movement of activated signaling proteins within mains are accessible for transcriptional induction by
transcytoplasmic signaling pathways in each cell type.the cell is essential, particularly for transcytoplasmic
signal transmission, where phosphorylation triggers the The apparent redundancy in signaling pathways is
another challenge in understanding specificity. Redun-translocation of proteins in and out of the nucleus. For
instance, tyrosine phosphorylation of Stats induces their dancy is evident from the finding that mutation of individ-
ual tyrosine phosphorylation sites in a receptor PTKdimerization and nuclear import, and phosphorylation
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often does not abolish a specific response, or even af- through phosphorylation and dephosphorylation and also
fect the spectrum of genes induced upon receptor acti- by protein degradation. Thus, ligand-induced receptor
vation (Valius and Kazlauskas, 1993; Fambrough et al., PTK signaling can be negatively regulated by receptor
1999). This may be explained by the existence of more endocytosis, dephosphorylation, feedback serine phos-
than one means of activating a critical pathway (e.g., phorylation, by binding of inhibitory proteins including
the Ras MAP kinase pathway can be activated by several inhibitory ligands, and through phosphorylation-depen-
distinct mechanisms). Where there are several closely dent ubiquitination and degradation. The recruitment
related proteins in a family, there can also be functional of nonreceptor PTPs such as Shp1 either to receptors
redundancy. A good example is the Src PTK family, themselves or to inhibitory receptors (e.g., KIRs) or in-
where c-Src, Fyn, and c-Yes are commonly coex- hibitory signaling proteins (e.g., SIRPs) is one mecha-
pressed, and where any one of the three can be sufficient nism to downregulate receptor PTK signaling (Moghal
to propagate a signal requiring a Src family PTK (Kling- and Sternberg, 1999). Interestingly a number of SH2
hoffer et al., 1999). domain proteins, including Socs, Cbl, and Dok family
Signal pathway cross-talk will become increasingly members have recently been shown to act as negative
important for our understanding of signaling networks. regulators of PTK signaling. Negative regulation of sig-
Cross-talk can occur between pathways activated by a naling may well turn out to be as important as positive
single receptor, or more commonly by pathways acti- regulation in understanding the specificity of signaling
vated by different receptors. Indeed, integration of cellu- networks.
lar responses elicited by different receptors must occur Role of Protein Kinases and Phosphatases
by cross-talk. There are already well-established links in Disease
between G protein±coupled receptors and receptor Increasing numbers of human diseases are known to
PTKs, and between integrin adhesion receptors and re- involve mutations, overexpression, or malfunctioning of
ceptor PTKs, to name just two examples (Luttrell et al., protein kinases and phosphatases, and their regulators
1999; Moghal and Sternberg, 1999). Cross-talk can take and effectors. The realization that protein kinases might
place at many levels from the membrane to the nucleus, play a direct role in disease came with the discovery
and involve components that are in common between that the v-Src oncoprotein is a PTK. Subsequently, a
two pathways, as well as positive and negative feedback plethora of diseases have been show to be due to muta-
signals that can act at many steps in a pathway from tions that activate or inactivate PTKs and PTPs, or lead
transcription factors to the receptors themselves. On to their misexpression and/or overexpression (Hunter,
the other side of the coin, pathway insulation to prevent 1998b). At least 18 PTK genes have been identified as
cross-talk is proving an increasingly important concept. oncogenes either in acutely transforming retroviruses
For instance, scaffolding proteins that assemble protein or in human tumors. Mutations in PTKs are also involved
kinase signaling cascades insulate related MAPK path- in other diseases. In particular, mutational inactivation
ways (Whitmarsh and Davis, 1998). of nonreceptor PTKs is observed in several immunodefi-
Another important concept in signaling specificity is ciency diseases. Inactivation of both copies of ZAP70
signal thresholds. In many systems a 2-fold decrease or JAK3 causes severe combined immunodeficiency,
in the level of a signaling protein can be sufficient to and mutation of the X-linked BTK gene results in agam-
abrogate signaling, and conversely a 2-fold increase can maglobulinemia.
initiate signaling. Moreover, signaling thresholds may Given the importance of activated PTKs in cancer,
be different in different cell types. Productive signaling one might have anticipated that PTP genes would be
can occur with only a few hundred activated receptor found as tumor suppressor genes. So far this has not
molecules per cell, and therefore there has to be signifi- proved to be the case. However, there has been recent
cant signal amplification. In this context, one aspect of excitement over the finding that the PTEN/MMAC gene,
receptor PTK signaling that is not well understood is
which is mutated in a variety of sporadic cancers and in
the fact that growth factor receptor signaling is needed
the hereditary Cowden's hamartoma cancer syndrome,
for 6±8 hr before a cell is committed to respond, even
encodes a member of the dual-specificity protein phos-though all the early signaling events that have been so
phatase family. However, PTEN's main function inintensively studied are over by 1±2 hr, and the receptor
negative growth regulation appears to be as a 39 phos-itself and the signaling pathways have been downregu-
phoinositide phosphatase, rather than as a proteinlated by degradation and negative feedback loops. It
phosphatase (Maehama and Dixon, 1998).remains unclear exactly what signal(s) is sensed by the
Many genetic diseases also result from mutations incell at later times. This also highlights the fact that most
protein-serine kinases and phosphatases. For instance,studies of ligand-induced signal transduction use acute
the Coffin-Lowry syndrome is due to inactivation of thestimulation with saturating doses of ligand, and often
X-linked Rsk2 protein-serine kinase gene, and myotonicoverexpressed receptors and heterologous cell types,
dystrophy is due to decreased levels of expression of theand one can question whether all of the responses that
myotonic dystrophy protein-serine kinase. In addition,are detected are physiologically relevant.
overexpression of the aurora2 protein-serine kinase isFinally, temporal aspects of signaling are also impor-
implicated in colon carcinoma, and the Lats1 and Lkb1tant in defining cellular responses. For instance, tran-
protein-serine kinases have both been identified as tu-sient activation of ERK MAPK by a receptor PTK in PC12
mor suppressors. Conversely, inactivating mutations incells fails to induce differentiation, whereas sustained
the Pr65 PP2A regulatory subunit are found in lung andERK MAP kinase activation induces neurite outgrowth
colon cancers.(Marshall, 1995). Signaling kinetics are governed by neg-
ative feedback systems that downregulate signaling As molecular analysis of human disease proceeds,
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one can predict that many additional somatic and hered- kinases and phosphatases are likely to be approved for
clinical use in the near future. In the next few years, weitary mutations with causal roles in disease will be found
in protein kinases and phosphatases, and in other sig- can anticipate that the rational structure-based design
and development of highly specific protein kinase andnaling proteins. These enzymes and proteins will be-
come candidates for the development of therapeutic phosphatase inhibitors (and activators) will become rou-
tine, and that drugs that intercede in phosphorylation-drugs.
Clinical Implications. In general enzymes make good mediated signaling pathways will become a major class
of drug.targets for drugs, and the widespread involvement of
protein kinases and phosphatases in disease has led to Genomics and Phosphorylation
Complete genome sequences have the potential to re-a massive effort to develop drugs that either activate
or more usually inhibit individual protein kinases and veal the totality of protein kinases and phosphatases
and phosphorylation-related signaling proteins expressedphosphatases. Drugs designed to target these enzymes
fall into two categoriesÐmonoclonal antibodies or mod- by a single organism. However, a priori assignment of
function to a gene product relies on its sequence beingified protein ligands, and small molecules. Significant
success has been achieved with the development of related to a protein of known function, and it clear that
not all of the types of proteins that mediate phosphoryla-small molecule inhibitors of a number of PTKs, and sev-
eral PTK inhibitors are either in or are beginning to enter tion-dependent signaling have yet been described.
Novel Protein Kinases and Phosphatases. Biochemi-clinical trials. One group of small molecule inhibitors in
cancer therapy trials target the EGF receptor or EGF cal and genomic analysis has already uncovered novel
types of protein kinases and phosphatases, distinctreceptor PTK family members. Another group of inhibi-
tors is directed against the VEGF receptor PTKs that from the major protein-serine/tyrosine kinase superfam-
ily and the known protein phosphatase families, and willare essential for tumor angiogenesis (Fong et al., 1999).
One receptor PTK antagonist, Herceptin, a monoclonal undoubtedly continue to do so. For example, one newly
described group of protein kinases (MHCK A, eEF-2antibody that blocks the function of the ErbB2 receptor
PTK, is already on the market, and is being used as an kinase, NFK, etc.) have a conserved catalytic domain
that is completely unrelated to that of the protein-serine/adjuvant breast cancer therapy in the significant fraction
of breast carcinomas where ErbB2 is overexpressed. tyrosine kinase superfamily (Ryazanov et al., 1999). Re-
cent sequence analysis has uncovered a set of microbialAnother disease being treated with a PTK inhibitor is
chronic myelogenous leukemia (CML), where a chromo- ªprotein kinaseº families (ABC1, piD261, RIO1 families,
and aminoglycoside kinases) that are all very distantlysomal translocation results in the expression of a chime-
ric Bcr-Abl protein that is a constitutively activated PTK related in sequence to the protein-serine/tyrosine kinase
superfamily catalytic domain, which are also repre-(Sawyers and Druker, 1999). CGP57148, a Bcr-Abl PTK
inhibitor, is proving very effective as a treatment for sented in budding yeast and C. elegans (Leonard et al.,
1998). These may represent the evolutionary origin of theCML. There are also protein-serine kinase inhibitors in
cancer clinical trials, including flavopiridol, a Cdk2 in- eukaryotic protein kinase superfamily. Histidine, lysine,
and arginine can be phosphorylated in proteins; how-hibitor.
A number of diseases are due to insufficient receptor ever, with the exception of a yeast histidine kinase that
phosphorylates histone H4, little is known about thePTK signaling, including noninsulin-dependent diabetes
and peripheral neuropathies. If it were possible to en- protein kinases that phosphorylate these residues, and
this will be an important task for the future.hance signaling through the receptors in question, this
could serve as a viable therapy. One way to do this New types of protein phosphatase will also emerge
to add to the currently known families of protein-serine,would be to find inhibitors of the cognate PTP for a
receptor PTK. One candidate emerges from the recent protein-tyrosine, and dual-specificity phosphatases. For
instance, the recently described CTD phosphatase,exciting finding that the knockout of PTP1B nonreceptor
PTP in the mouse results in insulin hypersensitivity, indi- which dephosphorylates the CTD of the large subunit
of RNA polymerase II, is a new type of protein-serinecating that PTP1B is a major insulin receptor PTK phos-
phatase (Elchebly et al., 1999). A PTP1B-specific inhibi- phosphatase (Cho et al., 1999). Moreover, like PTEN,
some members of the PTP superfamily may have non-tor has just entered clinical trials for diabetes. Another
candidate is the NGF receptor PTK, and a drug that protein phosphate ester substrates.
Protein Kinase and Phosphatase Catalogs. One excit-enhances NGF receptor signaling is also about to start
clinical trials. ing outcome of the ongoing genomic sequencing proj-
ects is that complete catalogs of protein kinases andSmall molecule activators of receptor PTKs have also
been developed. For instance, an activator of the insulin phosphatases will become available for increasingly
complex eukaryotic organisms. We already know thatreceptor PTK has recently been reported, which could
in principle act as an orally available insulin mimetic S. cerevisiae has 114 conventional protein kinase genes
(but no bona fide PTKs) out of 6,217 genes (1.8%)(Zhang et al., 1999). Interestingly, this pseudodimeric
molecule acts intracellularly, apparently by reorienting (Hunter and Plowman, 1997). The recently completed
sequence of C. elegans reveals that the worm genomethe two subunits of the insulin receptor dimer into an
active configuration in a redox-dependent manner. Like- encodes 400 protein kinase catalytic domains (92 are
PTKs 5 23%) out of 19,099 genes (2.1%) (Plowman etwise, small molecule activators of the G-CSF (Tian et
al., 1998) and erythropoietin (Wrighton et al., 1996; John- al., 1999). Based on the existence in public human EST
databases of .650 distinct protein kinases (.98 areson et al., 1998) binary receptor PTKs have been de-
veloped. PTKs 5 z16%) and extrapolation from C. elegans, the
human genome is predicted to encode .1100 proteinThe first small molecule drugs that act on protein
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kinases (z150 PTKs), assuming the human genome has genes are expressed in a particular cell, and sophisti-
about 80,000 genes. Indeed, it is almost inevitable that cated bioinformatics analysis. The new discipline of pro-
the ballyhooed millenary of protein kinases will be teomics, where protein modifications and interactions
reached! Analysis of the C. elegans genome shows that are analyzed in a high throughput format to provide
the number of protein phosphatases encoded is surpris- protein linkage maps and other information, will be of
ingly high, being more than half the number of protein fundamental importance in this endeavor. Databases
kinases. Indeed, there are hints that there can be one that catalog protein±protein and protein±small molecule
to one relationships between protein kinases and phos- interactions will also be an important step in this direc-
phatases (e.g., the Clr-1 receptor PTP and Egl-15 FGF tion. The availability of consensus sequences for induc-
receptor PTK in C. elegans) (Kokel et al., 1998). ible and constitutive protein±protein interactions and for
Comparative analysis of protein kinase and phospha- phosphorylation by particular protein kinases will also
tases from different species will tell us more about the be useful in predicting signaling connections.
evolution of different protein kinases. For instance, it is One of the major challenges will be to model protein±
already clear from the lack of bona fide PTKs in the protein interactions in vivo, where protein concentra-
yeasts and their presence in the simplest of multicellular tions are much higher than those used in vitro. High
eukaryotes that protein-tyrosine phosphorylation evolved protein concentrations favor low affinity interactions,
hand in hand with multicellularity, presumably in re- which are hard to measure in vitro and yet are likely
sponse to a need for intercellular communication. In to be important in signal propagation. Indeed, many
keeping with this idea, a majority of PTKs play a role in signaling assemblies may rely on a combination of multi-
transmembrane signaling in response to ligands that ple low-affinity interactions for their existence. Knowl-
bind to surface receptors. We will also learn which pro- edge of the concentration of a given protein at a particu-
tein kinases have been conserved throughout evolution, lar location in the cell will be critical information to
and which ones have a specialized function in a particu- obtain. Incorporation of kinetic and particularly spatial
lar type of organism. aspects of signaling into models will also be a serious
Such catalogs of protein kinases and phosphatases challenge; and given that several thousand different pro-
used in conjunction with detailed cellular expression teins could be involved in signaling in a single cell, the
patterns derived from expression array analysis will cir- computational difficulties will be immense. Nonetheless,
cumscribe which protein kinases and phosphatases are successful in silico analysis of signaling pathways and
present in a cell and can therefore be involved in any networks must be a major goal for the future.
particular phosphorylation event. This information, in Protein Phosphorylation Methodology
combination with the available repertoire of protein ki- Advances in methodology play a key role in progress in
nase target proteins and algorithms for simulating sig- most fields of biology, and this has certainly been true
naling networks, may allow predictions of signaling out- in the field of signal transduction in general and protein
comes in response to individual stimuli or combinations phosphorylation in particular. New methods will surely
of stimuli. also play a key role in future advances.
Signal Network Modeling: E-Phosphorylation. Analo- Genetic Analysis. Our understanding of signaling
gies have been drawn between cellular signaling net- pathways has benefited enormously from the use of
works and electronic circuits. Indeed cellular signaling organisms where genetic analysis is feasible. The highly
pathways have many of the attributes of electronic cir- conserved nature of most of the major signaling path-
cuits. Individual proteins can act as amplifiers or ways in eukaryotes allows use of genetic information
switches, and protein kinase cascades can act as serial obtained in one organism to predict the existence of
amplifiers or switches. Signal pathways can have posi- pathways and specific components in other organisms.
tive and negative feedback loops, and networks can be A good example is the elucidation of the MAPK path-
built up out of multiple signaling pathways.
ways where genetic analysis in yeast, C. elegans, and
Even though cell signaling networks are multidimen-
Drosophila was combined with biochemical analysis of
sional rather than two dimensional, their properties have
growth factor±stimulated protein kinases in mammalianencouraged attempts to develop predictive algorithms.
cells to provide a complete picture of this pathway.Efforts have been made to model MAPK cascades and
Genetic analysis of signaling systems will increasinglythe regulation of cell cycle transitions, and informative
be used to investigate the nature and function of signal-predictions have emerged. For instance, theoretical
ing pathways in vivo. Gene disruption through homolo-analysis of the ERK MAPK cascade has shown that it
gous recombination, selection of null mutants, or theacts as a switch to provide a very sharp activation curve
powerful new interfering double-stranded RNA (RNAi)in response to increasing levels of stimulus, rather than
ªknockoutº technology can be used to determineacting an amplifier (Huang and Ferrell, 1996). Ultimately,
whether a protein is essential for a given response. Inhowever, useful prediction of signaling pathways and
vertebrates, increasing use will be made of tissue-spe-networks will require a knowledge of all the players,
cific conditional knockouts, to circumvent potential de-their kinetic properties, their interaction partners and
fects in embryogenesis. Future genetic analysis of sig-mechanisms of positive and negative regulation, and
naling pathways will rely more and more on makingtheir subcellular localizations and concentrations. With
subtle germline mutations in organisms or cells (e.g.,the availability of complete genome sequences, efforts
inactivating point mutations) so that the gene productare underway to define all of the proteins involved in
is expressed at physiological levels at the correct timesignaling responses induced by specific receptors (e.g.,
and place, thus mitigating the potential problems withG protein coupled receptors). These efforts will be aided
by the use of expression array analysis to define which using overexpressed proteins and heterologous cell
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types. In the phosphorylation arena, the function of indi- (FRET) to monitor the timing and location of an intramo-
lecular interaction dependent upon protein kinase acti-vidual phosphorylation sites will be studied by mutating
them to a nonphosphorylatable residue to block phos- vation or phosphorylation. For instance, the localization
of activated protein kinase Ca has been imaged by ex-phorylation or an acidic residue that can mimic phos-
phorylation. Such an analysis of the functions of individ- pressing a GFP-tagged PKCa and microinjecting Cy3-
labeled anti-P.Thr250 antibodies, which recognize acti-ual tyrosine phosphorylation sites in the PDGF b
receptor PTK has recently been carried out by making vated phosphorylated PKCa (Ng et al., 1999).
Specific cell-permeant inhibitors of protein kinasesknockin mutations in the mouse germline (Heuchel et
al., 1999). Finally, genetic screens for suppressors and and phosphatases, and other signaling proteins are ex-
tremely powerful tools for analyzing signal transductionenhancers of sensitized conditional mutations, synthetic
lethal screens, and analysis of modifier genes will remain processes in intact cells. Many such inhibitors are al-
ready available and are extensively used. For instance,important tools in our armamentarium for analyzing sig-
naling pathways. there are nearly 2000 papers reporting the use of the
Parke-Davis MEK inhibitor PD98059, and over 1500Biochemical Analysis. Many new techniques have
been developed in the protein phosphorylation arena. where wortmannin has been used as a PI-39 kinase inhib-
itor. Phosphopeptides or other peptides that block pro-Traditionally, 32P labeling has been used to study protein
phosphorylation both in vivo and in vitro, but techniques tein±protein interactions are also increasingly used to
interdict signaling pathways. Conversely, rapid and re-that emphasize nonradioactive detection of phosphory-
lation are becoming more and more prominent (e.g., versible activation of exogenously expressed protein
kinases and phosphatases can be achieved by usingmeasurements of protein kinase activity using fluores-
cence anisotropy with fluorescently tagged peptides chemical inducers of homo- or heterodimerization, or
using 4-hydroxy tamoxifen to activate protein kinasesthat bind to phosphospecific antibodies upon phosphor-
ylation). Anti-P.Tyr antibodies have been widely used to and phosphatases fused to the estrogen receptor hor-
mone binding domain.detect tyrosine phosphorylation, but attempts to de-
velop anti-P.Ser and anti-P.Thr antibodies for similar The ongoing efforts of the pharmaceutical industry to
develop drugs that act as highly specific inhibitors (anduses have been less successful, because these antibod-
ies tend to recognize other phosphate esters, and are activators) of protein kinases and phosphatases has
already had significant benefits in basic research bygenerally of low affinity. Of much greater value have
been antibodies directed against specific P.Ser- and providing inhibitors as research tools. In many cases a
potent inhibitor of a target protein is developed, but forP.Thr-containing peptide sequences, corresponding to
known or suspected sites of phosphorylation. Phospho- a variety of reasons is not taken forward into clinic trials
or fails in trials. Such inhibitors as well as early deriva-specific antibodies against single or closely spaced
sites will be increasingly useful tools for studying serine/ tives of successful drugs are perfectly suited for analyti-
cal research. In the coming years, we can expect to seethreonine and tyrosine phosphorylation of individual
proteins by immunoprecipitation, immunoblotting, and increasing use of compounds from the pharmaceutical
industry as tools for investigating signaling processes.immunofluorescence staining. Analysis of histidine, ly-
sine, and arginine phosphorylation would be greatly fa- Protein Kinase and Phosphatase Substrates. Protein
kinases recognize their substrates in part through thecilitated by the development of antibodies against these
phosphoamino acids. primary sequence surrounding the phosphorylatable
residue. An emerging theme is that protein kinases alsoThe mapping of phosphorylation sites is a critical
endeavour, which traditionally has been done using recognize substrates via secondary docking sites dis-
tinct from primary phosphorylation sites (Holland and32P-labeling either in vivo or in vitro. However, within the
past few years mass spectrometry has emerged as the Cooper, 1999). This concept is well developed for PTKs
where SH2 and PTB domains are used to recruit sub-best method for identifying phosphorylation sites, and,
in the future, phosphorylation site mapping and mea- strates to specific P.Tyr residues in activated receptor
PTK dimers, triggering their phosphorylation. Protein-surements of phosphorylation stoichiometry will be ac-
complished routinely using mass spectrometry. serine kinases also recognize substrates through dock-
ing sites. For instance, JNK1/2 MAPKs interact specifi-Single Cell Analysis. It is imperative that we devise
better methods to study the kinetics and intracellular cally with a short LXL motif in the d region of c-Jun
via a loop in their C-terminal lobe, and ERK MAPKslocalization of signaling processes in single living cells,
so that spatiotemporal aspects of signaling can be de- recognize substrates via at least two distinct motifs (e.g.,
FXFP and LAQRRXXXXL/I) (Kallunki et al., 1994; Yangtermined. New assays to determine in real time where
in the cell a protein kinase is active using fluorescent et al., 1998; Gavin and Nebreda, 1999; Jacobs et al.,
1999; Smith et al., 1999). In addition, the G1 cyclin/reporter proteins will be important (e.g., using engi-
neered GFP derivatives with a grafted protein kinase Cdks select substrates through interaction of the cyclin
subunit via a ZRXL motif (Adams et al., 1996), and theconsensus sequence that exhibit fluorescence changes
upon phosphorylation by a specific protein kinase). The L45 loop in the N-terminal lobe of the TGFb type I recep-
tor catalytic domain interacts with a short sequencelocation and kinetics of specific phosphorylation events
can be monitored simultaneously in living cells using in the Smad2/3 MH2 domain (Chen et al., 1998). The
emerging picture is that a variety of surface loops onexpressed or microinjected fluorescent reporter pro-
teins (e.g., natural or artificial P.Ser or P.Tyr binding the catalytic domain as well as sites elsewhere in a
protein kinase can be used for selection of substrates.proteins and phosphospecific antibodies). Better yet,
one can use fluorescence resonance energy transfer Protein kinase catalytic domains interact with many
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types of protein including activators, inhibitors, tar- sequencing will probably be expressed and function in
specific neurons. From a technical standpoint a majorgeting proteins, and substrates. An important challenge
for the future will be to understand the structural bases requirement is the development of assays that allow
temporal analysis of signaling events at high spatial res-for these multiple protein kinase catalytic domain inter-
actions. olution in single cells. Also better methods for rapid
detection of phosphorylation, phosphorylation site map-One major problem in the protein phosphorylation
field is the difficulty in identifying true substrates for ping, and protein kinase and phosphate substrate identi-
fication are essential. The evolution of theoretical meth-individual protein kinases and phosphatases in vivo.
Specific protein kinase inhibitors can be useful, but it ods for analyzing signaling networks and sophisticated
protein interaction databases to support modeling ef-is hard to prove that they are truly selective in vivo.
A new substrate detection method has recently been forts is another obvious need. From a practical stand-
point, one can foresee that the accumulating knowledgedeveloped in which the ATP-binding site of a protein
kinase is ªenlargedº by mutation to accept an N6-modi- about signaling networks and the proteins involved will
permit development of potent and specific pharmaco-fied ATP analog, which can be used as a phosphate
donor for the mutant protein kinase when expressed in logical modulators of signaling that can be used thera-
peutically. Finally, we should not be so arrogant as tovivo but which cannot be used by other normal cellular
protein kinase (Liu et al., 1998). This method has been think that we already know all the possible principles of
signaling, and we should certainly expect totally newvalidated with members of the Src PTK family, and ef-
forts are currently being made to extend this to other types of signaling systems to be uncovered.
PTKs and to protein-serine kinases.
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